{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:23:07Z","timestamp":1792653787543,"version":"4.5.0"},"reference-count":60,"publisher":"Society for Neuroscience","issue":"30","license":[{"start":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T00:00:00Z","timestamp":1359072000000},"content-version":"vor","delay-in-days":184,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neurosci."],"accepted":{"date-parts":[[2012,6,6]]},"published-print":{"date-parts":[[2012,7,25]]},"abstract":"<jats:p>Overproduction of proinflammatory cytokines in the CNS has been implicated as a key contributor to pathophysiology progression in Alzheimer's disease (AD), and extensive studies with animal models have shown that selective suppression of excessive glial proinflammatory cytokines can improve neurologic outcomes. The prior art, therefore, raises the logical postulation that intervention with drugs targeting dysregulated glial proinflammatory cytokine production might be effective disease-modifying therapeutics if used in the appropriate biological time window. To test the hypothesis that early stage intervention with such drugs might be therapeutically beneficial, we examined the impact of intervention with MW01-2-151SRM (MW-151), an experimental therapeutic that selectively attenuates proinflammatory cytokine production at low doses. MW-151 was tested in an APP\/PS1 knock-in mouse model that exhibits increases in AD-relevant pathology progression with age, including increases in proinflammatory cytokine levels. Drug was administered during two distinct but overlapping therapeutic time windows of early stage pathology development. MW-151 treatment attenuated the increase in microglial and astrocyte activation and proinflammatory cytokine production in the cortex and yielded improvement in neurologic outcomes, such as protection against synaptic protein loss and synaptic plasticity impairment. The results also demonstrate that the therapeutic time window is an important consideration in efficacy studies of drugs that modulate glia biological responses involved in pathology progression and suggest that such paradigms should be considered in the development of new therapeutic regimens that seek to delay the onset or slow the progression of AD.<\/jats:p>","DOI":"10.1523\/jneurosci.1496-12.2012","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T18:06:15Z","timestamp":1343844375000},"page":"10201-10210","source":"Crossref","is-referenced-by-count":90,"title":["Early Stage Drug Treatment That Normalizes Proinflammatory Cytokine Production Attenuates Synaptic Dysfunction in a Mouse Model That Exhibits Age-Dependent Progression of Alzheimer's Disease-Related Pathology"],"prefix":"10.1523","volume":"32","author":[{"given":"Adam D.","family":"Bachstetter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradoldej","family":"Sompol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Wilcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Goulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna H.","family":"Neltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daret","family":"St. Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Martin","family":"Watterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J.","family":"Van Eldik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"393","published-online":{"date-parts":[[2012,7,25]]},"reference":[{"key":"2025030704090603000_32.30.10201.1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.051223"},{"key":"2025030704090603000_32.30.10201.2","doi-asserted-by":"publisher","DOI":"10.1038\/361031a0"},{"key":"2025030704090603000_32.30.10201.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2010.12.014"},{"key":"2025030704090603000_32.30.10201.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.07.012"},{"key":"2025030704090603000_32.30.10201.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05625-2"},{"key":"2025030704090603000_32.30.10201.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.10.006"},{"key":"2025030704090603000_32.30.10201.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.087031"},{"key":"2025030704090603000_32.30.10201.8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507313103"},{"key":"2025030704090603000_32.30.10201.9","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2009.1227"},{"key":"2025030704090603000_32.30.10201.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2010.02.002"},{"key":"2025030704090603000_32.30.10201.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2004.01.006"},{"key":"2025030704090603000_32.30.10201.12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/JMN:24:1:115","article-title":"Aminopyridazines attenuate hippocampus dependent behavioral deficits induced by human A\u03b2 in a murine model of neuroinflammation","volume":"24","author":"Craft","year":"2004","journal-title":"J Mol Neurosci"},{"key":"2025030704090603000_32.30.10201.13","doi-asserted-by":"publisher","DOI":"10.1038\/nature09612"},{"key":"2025030704090603000_32.30.10201.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(01)00330-X"},{"key":"2025030704090603000_32.30.10201.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04165.x"},{"key":"2025030704090603000_32.30.10201.16","first-page":"19","article-title":"Neuroinflammatory cytokines \u2013 the common thread in Alzheimer's pathogenesis","volume":"6","author":"Griffin","year":"2010","journal-title":"US Neurol"},{"key":"2025030704090603000_32.30.10201.17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","article-title":"The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE","volume":"33","author":"Guerreiro","year":"2012","journal-title":"Neurobiol Aging"},{"key":"2025030704090603000_32.30.10201.18","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200705042"},{"key":"2025030704090603000_32.30.10201.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2009.10.002"},{"key":"2025030704090603000_32.30.10201.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.040"},{"key":"2025030704090603000_32.30.10201.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2006.10.028"},{"key":"2025030704090603000_32.30.10201.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010178"},{"key":"2025030704090603000_32.30.10201.23","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1523\/JNEUROSCI.22-06-02246.2002","article-title":"Microglial activation and \u03b2-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice","volume":"22","author":"Jantzen","year":"2002","journal-title":"J Neurosci"},{"key":"2025030704090603000_32.30.10201.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.06.039"},{"key":"2025030704090603000_32.30.10201.25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100620"},{"key":"2025030704090603000_32.30.10201.26","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn008"},{"key":"2025030704090603000_32.30.10201.27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/gps.2723","article-title":"Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's disease anti-inflammatory prevention trial","volume":"27","author":"Leoutsakos","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"key":"2025030704090603000_32.30.10201.28","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease","volume":"20","author":"Lim","year":"2000","journal-title":"J Neurosci"},{"key":"2025030704090603000_32.30.10201.29","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-28"},{"key":"2025030704090603000_32.30.10201.30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/neuro.24.006.2009","article-title":"Age-related neuroinflammatory changes negatively impact on neuronal function","volume":"1","author":"Lynch","year":"2010","journal-title":"Front Aging Neurosci"},{"key":"2025030704090603000_32.30.10201.31","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5435.1870"},{"key":"2025030704090603000_32.30.10201.32","first-page":"2330","article-title":"Preparation of acute hippocampal slices from rats and transgenic mice for the study of synaptic alterations during aging and amyloid pathology","volume":"pii","author":"Mathis","year":"2011","journal-title":"J Vis Exp"},{"key":"2025030704090603000_32.30.10201.33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.2.425"},{"key":"2025030704090603000_32.30.10201.34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300668"},{"key":"2025030704090603000_32.30.10201.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2004.05.010"},{"key":"2025030704090603000_32.30.10201.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2007.06.002"},{"key":"2025030704090603000_32.30.10201.37","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e3181919a48"},{"key":"2025030704090603000_32.30.10201.38","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-011-0826-y"},{"key":"2025030704090603000_32.30.10201.39","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2009.1029"},{"key":"2025030704090603000_32.30.10201.40","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4652-05.2006"},{"key":"2025030704090603000_32.30.10201.41","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132528"},{"key":"2025030704090603000_32.30.10201.42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.38.23380"},{"key":"2025030704090603000_32.30.10201.43","doi-asserted-by":"publisher","DOI":"10.1042\/BST0351219"},{"key":"2025030704090603000_32.30.10201.44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M800148200"},{"key":"2025030704090603000_32.30.10201.45","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-7"},{"key":"2025030704090603000_32.30.10201.46","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1523\/JNEUROSCI.20-23-08717.2000","article-title":"Presenilin-1 P264L knock-in mutation: differential effects on A\u03b2 production, amyloid deposition, and neuronal vulnerability","volume":"20","author":"Siman","year":"2000","journal-title":"J Neurosci"},{"key":"2025030704090603000_32.30.10201.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2009.12.004"},{"key":"2025030704090603000_32.30.10201.48","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1528-1167.2007.01135.x","article-title":"Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of pro-inflammatory cytokine upregulation","volume":"48","author":"Somera-Molina","year":"2007","journal-title":"Epilepsia"},{"key":"2025030704090603000_32.30.10201.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2009.05.073"},{"key":"2025030704090603000_32.30.10201.50","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4158-11.2011"},{"key":"2025030704090603000_32.30.10201.51","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20101"},{"key":"2025030704090603000_32.30.10201.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(07)82015-0"},{"key":"2025030704090603000_32.30.10201.53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/156720506777632844","article-title":"De novo and molecular target-independent discovery of orally bioavailable lead compounds for neurological disorders","volume":"3","author":"Wing","year":"2006","journal-title":"Curr Alzheimer Res"},{"key":"2025030704090603000_32.30.10201.54","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006346"},{"key":"2025030704090603000_32.30.10201.55","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-6-84"},{"key":"2025030704090603000_32.30.10201.56","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.060378"},{"key":"2025030704090603000_32.30.10201.57","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters \u03b2-amyloid processing and deposition in an animal model of Alzheimer's disease","volume":"23","author":"Yan","year":"2003","journal-title":"J Neurosci"},{"key":"2025030704090603000_32.30.10201.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2010.10.015"},{"key":"2025030704090603000_32.30.10201.59","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(01)00297-4"},{"key":"2025030704090603000_32.30.10201.60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1742-2094-9-47","article-title":"Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways","volume":"9","author":"Zilka","year":"2012","journal-title":"J Neuroinflammation"}],"container-title":["The Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.1496-12.2012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T17:13:04Z","timestamp":1741367584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jneurosci.org\/lookup\/doi\/10.1523\/JNEUROSCI.1496-12.2012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,25]]},"references-count":60,"journal-issue":{"issue":"30","published-online":{"date-parts":[[2012,7,25]]},"published-print":{"date-parts":[[2012,7,25]]}},"alternative-id":["10.1523\/JNEUROSCI.1496-12.2012"],"URL":"https:\/\/doi.org\/10.1523\/jneurosci.1496-12.2012","relation":{},"ISSN":["0270-6474","1529-2401"],"issn-type":[{"value":"0270-6474","type":"print"},{"value":"1529-2401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,25]]}}}